Compositions and methods for modulating kinase activity
Abstract
The present invention features an antibody mimetic, or an antigen binding fragment thereof, that specifically binds to an allosteric site of Aurora A kinase, therapeutic compositions comprising this antibody mimetic, and the use of the monobody to modulate Aurora A kinase for the treatment of cancer.
- Inventors:
- Issue Date:
- Research Org.:
- Brandeis Univ., Waltham, MA (United States)
- Sponsoring Org.:
- USDOE; National Institutes of Health (NIH)
- OSTI Identifier:
- 1840386
- Patent Number(s):
- 11104741
- Application Number:
- 15/774,747
- Assignee:
- Brandeis University (Waltham, MA)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
- DOE Contract Number:
- FG02-05ER15699; GM096053; GM100966-01
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 01/27/2016
- Country of Publication:
- United States
- Language:
- English
Citation Formats
Kern, Dorothee, and Zorba, Adelajda. Compositions and methods for modulating kinase activity. United States: N. p., 2021.
Web.
Kern, Dorothee, & Zorba, Adelajda. Compositions and methods for modulating kinase activity. United States.
Kern, Dorothee, and Zorba, Adelajda. Tue .
"Compositions and methods for modulating kinase activity". United States. https://www.osti.gov/servlets/purl/1840386.
@article{osti_1840386,
title = {Compositions and methods for modulating kinase activity},
author = {Kern, Dorothee and Zorba, Adelajda},
abstractNote = {The present invention features an antibody mimetic, or an antigen binding fragment thereof, that specifically binds to an allosteric site of Aurora A kinase, therapeutic compositions comprising this antibody mimetic, and the use of the monobody to modulate Aurora A kinase for the treatment of cancer.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2021},
month = {8}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain
journal, July 2016
- Burgess, Selena G.; Oleksy, Arkadiusz; Cavazza, Tommaso
- Open Biology, Vol. 6, Issue 7
Molecular Affinity Clamp Technology and Uses Thereof
patent-application, June 2011
- Koide, Shohei; Koide, Akiko; Huang, Jin
- US Patent Application 12/742014; 20110143963
Crystal structure of enzyme and uses thereof
patent-application, April 2006
- Anderson, Malcom; Keen, Nicholas John; Pannifer, Andrew David Bruce
- US Patent Application 10/491854; 20060078975
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
journal, March 2010
- Wojcik, John; Hantschel, Oliver; Grebien, Florian
- Nature Structural & Molecular Biology, Vol. 17, Issue 4
Crystals of an Aurora-A Tpx2 Complex, Tpx2 Binding Site of Aurora-A, Aurora-A Ligands and Their Use
patent-application, February 2008
- Conti, Elena; Bayliss, Richard; Schultz, Carsten
- US Patent Application 10/574575; 20080051327
Allosteric Protein Kinase Modulators
patent-application, February 2012
- Engel, Matthias; Frohner, Wolfgang; Stroba, Adriane
- US Patent Application 13/124773; 20120046307
Phospho-regulation of human protein kinase Aurora-A: analysis using anti-phospho-Thr288 monoclonal antibodies
journal, June 2006
- Ohashi, S.; Sakashita, G.; Ban, R.
- Oncogene, Vol. 25, Issue 59
Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2
journal, June 2016
- Janeček, Matej; Rossmann, Maxim; Sharma, Pooja
- Scientific Reports, Vol. 6, Issue 1
High-Throughput Ligand Discovery Reveals a Sitewise Gradient of Diversity in Broadly Evolved Hydrophilic Fibronectin Domains
journal, September 2015
- Woldring, Daniel R.; Holec, Patrick V.; Zhou, Hong
- PLOS ONE, Vol. 10, Issue 9